Page last updated: 2024-08-24

halofuginone and Diabetic Glomerulosclerosis

halofuginone has been researched along with Diabetic Glomerulosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujimoto, M; Halevi, K; Kawamura, H; Koshizaka, M; Maezawa, Y; Saito, Y; Sato, S; Shimoyama, T; Takemoto, M; Tsurutani, Y; Ueda, S; Watanabe, A; Yokote, K	1

Other Studies

1 other study(ies) available for halofuginone and Diabetic Glomerulosclerosis

Article	Year
Halofuginone prevents extracellular matrix deposition in diabetic nephropathy. Biochemical and biophysical research communications, 2009, Feb-06, Volume: 379, Issue:2 Topics: Animals; Collagen Type I; Diabetic Nephropathies; Extracellular Matrix; Fibronectins; Mesangial Cells; Mice; Mice, Inbred Strains; Oxidative Stress; Piperidines; Quinazolinones; Rats; Smad2 Protein; Transforming Growth Factor beta	2009

Article

Year

Halofuginone prevents extracellular matrix deposition in diabetic nephropathy.

Biochemical and biophysical research communications, 2009, Feb-06, Volume: 379, Issue:2

Topics: Animals; Collagen Type I; Diabetic Nephropathies; Extracellular Matrix; Fibronectins; Mesangial Cells; Mice; Mice, Inbred Strains; Oxidative Stress; Piperidines; Quinazolinones; Rats; Smad2 Protein; Transforming Growth Factor beta

2009